The USER Study: A Chart Review of Patients Receiving a 0.2 Μg/Day Fluocinolone Acetonide Implant for Diabetic Macular Edema
Ophthalmology and Therapy - United Kingdom
doi 10.1007/s40123-018-0155-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 17, 2018
Authors
Publisher
Springer Science and Business Media LLC